The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections
Open accessAbstract
SUMMARY: Epstein-Barr virus (EBV) is a gammaherpesvirus that infects a large fraction of the human population. Primary infection is often asymptomatic but results in lifelong infection, which is kept in check by the host immune system. In some cases, primary infection can result in infectious mononucleosis. Furthermore, when host-virus balance is not achieved, the virus can drive potentially lethal lymphoproliferation and lymphomagenesis. In this review, we describe the biology of EBV and the host immune response. We review the diagnosis of EBV infection and discuss the characteristics and pathogenesis of infectious mononucleosis. These topics are approached in the context of developing therapeutic and preventative strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA
Epstein, M. A., Achong, B. G., & Barr, Y. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91524-7 · Cited by 2,778
Epstein–Barr virus: 40 years on
Young, L. S., & Rickinson, A. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1452 · Cited by 2,227
Rickinson, A. (2001) · Virus Research · doi:10.1016/s0168-1702(01)00436-1 · Cited by 2,179
Epstein-Barr virus and its replication
Kieff, E. D. (1996) · Medical Entomology and Zoology · Cited by 1,627
Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine
Elion, G. B., Furman, P. A., Fyfe, J. A., Miranda, P. D., Beauchamp, L., & Schaeffer, H. J. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5716 · Cited by 1,591
Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI
Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A., & Mosmann, T. R. (1990) · Science · doi:10.1126/science.2161559 · Cited by 1,143
(1948) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1948.tb28186.x · Cited by 1,141
Interleukin‐10: new perspectives on an old cytokine
Mosser, D. M., & Zhang, X. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00706.x · Cited by 1,077
Persistence of the Epstein–Barr Virus and the Origins of Associated Lymphomas
Thorley-Lawson, D. A., & Gross, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032015 · Cited by 1,054
Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S., Notarangelo, L., Geha, R., Roncarolo, M. G., et al. (1998) · Nature · doi:10.1038/26683 · Cited by 943
EBV Persistence in Memory B Cells In Vivo
Babcock, G. J., Decker, L. L., Volk, M., & Thorley-Lawson, D. A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80622-6 · Cited by 825
Cellular responses to viral infection in humans: lessons from Epstein–Barr virus
Hislop, A. D., Taylor, G. S., Sauce, D., & Rickinson, A. B. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141553 · Cited by 766
Herpesvirus latency confers symbiotic protection from bacterial infection
Barton, E. S., White, D. W., Cathelyn, J. S., Brett-McClellan, K. A., Engle, M., Diamond, M. S., Miller, V. L., & Virgin, H. W. (2007) · Nature · doi:10.1038/nature05762 · Cited by 763
Coffey, A. J., Brooksbank, R. A., Brandau, O., Oohashi, T., Howell, G. R., Bye, J. M., Cahn, A. P., Durham, J., Heath, P., Wray, P., et al. (1998) · Nature Genetics · doi:10.1038/2424 · Cited by 754
Haque, T., Wilkie, G. M., Jones, M. M., Higgins, C. D., Urquhart, G., Wingate, P., Burns, D., McAulay, K., Turner, M., Bellamy, C., et al. (2007) · Blood · doi:10.1182/blood-2006-12-063008 · Cited by 648
SAP-controlled T–B cell interactions underlie germinal centre formation
Qi, H., Cannons, J. L., Klauschen, F., Schwartzberg, P. L., & Germain, R. N. (2008) · Nature · doi:10.1038/nature07345 · Cited by 637 · cited 1×
“The SAP protein is a signaling molecule downstream of SLAM receptors, which are important in B-cell activation of T cells and NK cells (29, 82, 152, 164).”
BackgroundLuzuriaga, K., & Sullivan, J. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1001116 · Cited by 606
EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS
Paya, C. V., Fung, J. J., Nalesnik, M. A., Kieff, E., Green, M., Gores, G., Habermann, T. M., Wiesner, R. H., Swinnen, L. J., Woodle, E. S., et al. (1999) · Transplantation · doi:10.1097/00007890-199911270-00015 · Cited by 533
Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome
Nichols, K. E., Harkin, D. P., Levitz, S., Krainer, M., Kolquist, K. A., Genovese, C., Bernard, A., Ferguson, M., Zuo, L., Snyder, E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13765 · Cited by 498
Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes
Sample, J., Young, L., Martin, B., Chatman, T., Kieff, E., Rickinson, A., & Kieff, E. (1990) · Journal of Virology · doi:10.1128/jvi.64.9.4084-4092.1990 · Cited by 497
Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus
Borza, C. M., & Hutt-Fletcher, L. M. (2002) · Nature Medicine · doi:10.1038/nm0602-594 · Cited by 484
Antiviral immune responses: triggers of or triggered by autoimmunity?
Münz, C., Lünemann, J. D., Getts, M. T., & Miller, S. D. (2009) · Nature Reviews Immunology · doi:10.1038/nri2527 · Cited by 480
X-Linked Lymphoproliferative Disease
Parolini, S., Bottino, C., Falco, M., Augugliaro, R., Giliani, S., Franceschini, R., Ochs, H. D., Wolf, H., Bonnefoy, J.-Y., Biassoni, R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.337 · Cited by 477
Evolutionary struggles between NK cells and viruses
Lanier, L. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2276 · Cited by 451
Sokal, E. M., Hoppenbrouwers, K., Vandermeulen, C., Moutschen, M., Léonard, P., Moreels, A., Haumont, M., Bollen, A., Smets, F., & Denis, M. (2007) · The Journal of Infectious Diseases · doi:10.1086/523813 · Cited by 426
Weller, S., Blum, M. R., Doucette, M., Burnette, T., Cederberg, D. M., de Miranda, P., & Smiley, M. L. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.196 · Cited by 395
Regulation of NKT cell development by SAP, the protein defective in XLP
Nichols, K. E., Hom, J., Gong, S.-Y., Ganguly, A., Ma, C. S., Cannons, J. L., Tangye, S. G., Schwartzberg, P. L., Koretzky, G. A., & Stein, P. L. (2005) · Nature Medicine · doi:10.1038/nm1189 · Cited by 391
Kalil, A. C., Levitsky, J., Lyden, E., Stoner, J., & Freifeld, A. G. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-12-200512200-00005 · Cited by 389
Khanna, R., Burrows, S. R., Kurilla, M. G., Jacob, C. A., Misko, I. S., Sculley, T. B., Kieff, E., & Moss, D. J. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.169 · Cited by 384
Zhang, Y., Wallace, D. L., De Lara, C. M., Ghattas, H., Asquith, B., Worth, A., Griffin, G. E., Taylor, G. P., Tough, D. F., Beverley, P. C. L., et al. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02573.x · Cited by 376
van Esser, J. W. J., van der Holt, B., Meijer, E., Niesters, H. G. M., Trenschel, R., Thijsen, S. F. T., van Loon, A. M., Frassoni, F., Bacigalupo, A., Schaefer, U. W., et al. (2001) · Blood · doi:10.1182/blood.v98.4.972 · Cited by 373
Rickinson, A. B., Young, L. S., & Rowe, M. (1987) · Journal of Virology · doi:10.1128/jvi.61.5.1310-1317.1987 · Cited by 369
Hodson, E. M., Jones, C. A., Webster, A. C., Strippoli, G. F., Barclay, P. G., Kable, K., Vimalachandra, D., & Craig, J. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66553-1 · Cited by 350
Khanna, R., Bell, S. C., Sherritt, M. A., Galbraith, A. J., Burrows, S. R., Rafter, L., Clarke, B., Slaughter, R., Falk, M. C., Douglass, J. A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10391 · Cited by 340
Human natural killer cell deficiencies and susceptibility to infection
Orange, J. S. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)00038-2 · Cited by 338
Molecular Diagnosis of Epstein-Barr Virus-Related Diseases
Gulley, M. L. (2001) · The Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60642-3 · Cited by 335
THE PRESENCE OF HETEROPHILE ANTIBODIES IN INFECTIOUS MONONUCLEOSIS
Paul, J. R., & Bunnell, W. W. (1932) · The American Journal of the Medical Sciences · doi:10.1097/00000441-193201000-00010 · Cited by 328
Bottino, C., Falco, M., Parolini, S., Marcenaro, E., Augugliaro, R., Sivori, S., Landi, E., Biassoni, R., Notarangelo, L. D., Moretta, L., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.3.235 · Cited by 310
Iwakiri, D., Zhou, L., Samanta, M., Matsumoto, M., Ebihara, T., Seya, T., Imai, S., Fujieda, M., Kawa, K., & Takada, K. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081761 · Cited by 309
Roizman, B., Whitley, R. J., & Lopez, C. (1993) · Medical Entomology and Zoology · Cited by 294
Geographical prevalence of two types of Epstein-Barr virus
Zimber, U., Adldinger, H. K., Lenoir, G. M., Vuillaume, M., Knebel-Doeberitz, M. V., Laux, G., Des̀granges, C., Wittmann, P., Freese, U.-K., Schneider, U., et al. (1986) · Virology · doi:10.1016/0042-6822(86)90429-0 · Cited by 290
Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells
Tugizov, S. M., Berline, J. W., & Palefsky, J. M. (2003) · Nature Medicine · doi:10.1038/nm830 · Cited by 286
Balfour, H. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401608 · Cited by 285
Self-citationKikuta, H., Taguchi, Y., Tomizawa, K., Kojima, K., Kawamura, N., Ishizaka, A., Sakiyama, Y., Matsumoto, S., Imai, S., Kinoshita, T., et al. (1988) · Nature · doi:10.1038/333455a0 · Cited by 281
Driscoll, J. S. (2002) · Cited by 273
Savoie, A., Perpete, C., Carpentier, L., Joncas, J. H., & Alfieri, C. (1994) · Blood · doi:10.1182/blood.v83.9.2715.2715 · Cited by 264
Blake, N., Lee, S., Redchenko, I., Thomas, W., Steven, N., Leese, A., Steigerwald-Mullen, P., Kurilla, M. G., Frappier, L., & Rickinson, A. (1997) · Immunity · doi:10.1016/s1074-7613(00)80397-0 · Cited by 261
Ohshima, K., Kimura, H., Yoshino, T., Kim, C. W., Ko, Y. H., Lee, S., Peh, S., Chan, J. K. C., & The CAEBV Study Group (2008) · Pathology International · doi:10.1111/j.1440-1827.2008.02213.x · Cited by 247
Latent and lytic Epstein‐Barr virus replication strategies
Tsurumi, T., Fujita, M., & Kudoh, A. (2005) · Reviews in Medical Virology · doi:10.1002/rmv.441 · Cited by 241
Acute complications of Epstein-Barr virus infectious mononucleosis
Jenson, H. B. (2000) · Current Opinion in Pediatrics · doi:10.1097/00008480-200006000-00016 · Cited by 233
Hess, R. D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.8.3381-3387.2004 · Cited by 232
Weck, K. E., Dal Canto, A. J., Gould, J. D., O'Guin, A. K., Roth, K. A., Saffitz, J. E., Speck, S. H., & Virgin, H. W. (1997) · Nature Medicine · doi:10.1038/nm1297-1346 · Cited by 223
Reactivation of Epstein-Barr virus from latency
Amon, W., & Farrell, P. J. (2005) · Reviews in Medical Virology · doi:10.1002/rmv.456 · Cited by 223
X-Linked Lymphoproliferative Disease: A Progressive Immunodeficiency
Morra, M., Howie, D., Grande, M. S., Sayos, J., Wang, N., Wu, C., Engel, P., & Terhorst, C. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.657 · Cited by 223
Wagner, H.-J., Wessel, M., Jabs, W., Smets, F., Fischer, L., Offner, G., & Bucsky, P. (2001) · Transplantation · doi:10.1097/00007890-200109270-00006 · Cited by 218
Crawford, D. H., Macsween, K. F., Higgins, C. D., Thomas, R., McAulay, K., Williams, H., Harrison, N., Reid, S., Conacher, M., Douglas, J., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/505400 · Cited by 209
Chesnokova, L. S., Nishimura, S. L., & Hutt-Fletcher, L. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907508106 · Cited by 208
Balfour, Jr., Holman, C. J., Hokanson, K. M., Lelonek, M. M., Giesbrecht, J. E., White, D. R., Schmeling, D. O., Webb, C., Cavert, W., Wang, D. H., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/491740 · Cited by 200
The immune response to primary EBV infection: a role for natural killer cells
Williams, H., McAulay, K., Macsween, K. F., Gallacher, N. J., Higgins, C. D., Harrison, N., Swerdlow, A. J., & Crawford, D. H. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05452.x · Cited by 197
Epstein-Barr virus and human diseases: recent advances in diagnosis
Okano, M., Thiele, G. M., Davis, J. R., Grierson, H. L., & Purtilo, D. T. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.3.300 · Cited by 190
Activated lymphocytes during acute Epstein-Barr virus infection.
Tomkinson, B. E., Wagner, D. K., Nelson, D. L., & Sullivan, J. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.11.3802 · Cited by 185
Molecular virology of Epstein–Barr virus
Bornkamm, G. W., & Hammerschmidt, W. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2000.0781 · Cited by 183
Hochberg, D., Souza, T., Catalina, M., Sullivan, J. L., Luzuriaga, K., & Thorley-Lawson, D. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5194-5204.2004 · Cited by 181
Baldanti, F., Grossi, P., Furione, M., Simoncini, L., Sarasini, A., Comoli, P., Maccario, R., Fiocchi, R., & Gerna, G. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.2.613-619.2000 · Cited by 180
Memory of mice and men: CD8+ T‐cell cross‐reactivity and heterologous immunity
Selin, L. K., Brehm, M. A., Naumov, Y. N., Cornberg, M., Kim, S., Clute, S. C., & Welsh, R. M. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00394.x · Cited by 177
Long‐Term Shedding of Infectious Epstein‐Barr Virus after Infectious Mononucleosis
Fafi‐Kremer, S., Morand, P., Brion, J., Pavese, P., Baccard, M., Germi, R., Genoulaz, O., Nicod, S., Jolivet, M., Ruigrok, R. W. H., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428097 · Cited by 174
Tynell, E., Aurelius, E., Brandell, A., Julander, I., Wood, M., Yao, Q.-Y., Rickinson, A., Akerlund, B., & Andersson, J. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.2.324 · Cited by 172
An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).
Burrows, S. R., Sculley, T. B., Misko, I. S., Schmidt, C., & Moss, D. J. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.1.345 · Cited by 170
Rowe, D. T., Webber, S., Schauer, E. M., Reyes, J., & Green, M. (2001) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.2001.003002079.x · Cited by 169
Tyring, S. K., Baker, D., & Snowden, W. (2002) · The Journal of Infectious Diseases · doi:10.1086/342966 · Cited by 169
Meng, Q., Hagemeier, S. R., Fingeroth, J. D., Gershburg, E., Pagano, J. S., & Kenney, S. C. (2010) · Journal of Virology · doi:10.1128/jvi.02487-09 · Cited by 162
Milone, M. C. (2004) · Blood · doi:10.1182/blood-2004-07-2965 · Cited by 158
The EBV-Encoded dUTPase Activates NF-κB through the TLR2 and MyD88-Dependent Signaling Pathway
Ariza, M. E., Glaser, R., Kaumaya, P. T. P., Jones, C., & Williams, M. V. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.2.851 · Cited by 158
Phase I Trial of a CD8+T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis
Elliott, S. L., Suhrbier, A., Miles, J. J., Lawrence, G., Pye, S. J., Le, T. T., Rosenstengel, A., Nguyen, T. H., Allworth, A. M., Burrows, S. R., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01409-07 · Cited by 151
Prospective study of the natural history of infectious mononucleosis caused by Epstein-Barr virus.
Rea, T. D., Russo, J. E., Katon, W. J., Ashley, R. L., & Buchwald, D. (2001) · PubMed · Cited by 146
Linde, A., Andersson, B., Svenson, S. B., Ahrne, H., Carlsson, M., Forsberg, P., Hugo, H., Karstorp, A., Lenkei, R., Lindwall, A., et al. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/165.6.994 · Cited by 142
Hayden, R. T., Hokanson, K. M., Pounds, S. B., Bankowski, M. J., Belzer, S. W., Carr, J., Diorio, D., Forman, M., Joshi, Y., Hillyard, D. R., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01252-07 · Cited by 138
Self-citationOn the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis
Hadinoto, V., Shapiro, M., Greenough, T. C., Sullivan, J. L., Luzuriaga, K., & Thorley‐Lawson, D. A. (2007) · Blood · doi:10.1182/blood-2007-06-093278 · Cited by 135
Manipulation of the Toll-Like Receptor 7 Signaling Pathway by Epstein-Barr Virus
Martin, H. J., Lee, J. M., Walls, D., & Hayward, S. D. (2007) · Journal of Virology · doi:10.1128/jvi.01122-07 · Cited by 133
Evidence-Based Approach for Interpretation of Epstein-Barr Virus Serological Patterns
Klutts, J. S., Ford, B. A., Perez, N. R., & Gronowski, A. M. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00164-09 · Cited by 132
THE CLINICAL MANIFESTATIONS OF INFECTIOUS MONONUCLEOSIS A REPORT OF TWO HUNDRED CASES
Hoagland, R. J. (1960) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196007000-00003 · Cited by 131
Rees, L., Tizard, E. J., Morgan, A. J., Cubitt, W. D., Finerty, S., Oyewole-Eletu, T., Owen, K., Royed, C., Stevens, S. J. C., Shroff, R. C., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e3181b9d918 · Cited by 127
Neurologic complications of infectious mononucleosis
Connelly, K. P., & DeWitt, L. D. (1994) · Pediatric Neurology · doi:10.1016/0887-8994(94)90021-3 · Cited by 121
Silins, S. L., Sherritt, M. A., Silleri, J. M., Cross, S., Elliott, S. L., Bharadwaj, M., Le, T. T., Morrison, L. E., Khanna, R., Moss, D. J., et al. (2001) · Blood · doi:10.1182/blood.v98.13.3739 · Cited by 121
Acyclovir and Epstein--Barr virus infection
Pagano, J. S., Sixbey, J. W., & Lin, J.-C. (1983) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/12.suppl_b.113 · Cited by 118
Epstein‐Barr virus promotes interferon‐α production by plasmacytoid dendritic cells
Quan, T. E., Roman, R. M., Rudenga, B. J., Holers, V. M., & Craft, J. E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27408 · Cited by 117
Lack of Effect of Peroral Acyclovir for the Treatment of Acute Infectious Mononucleosis
van der Horst, C., Joncas, J. H., Ahronheim, G. A., Gustafson, N., Stein, G., Gurwith, M., FLEISHER, G. R., Sullivan, J., Sixbey, J. W., Roland, S., et al. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/164.4.788 · Cited by 117
Hislop, A. D., Palendira, U., Leese, A. M., Arkwright, P. D., Rohrlich, P., Tangye, S. G., Gaspar, H. B., Lankester, A. C., Moretta, A., & Rickinson, A. B. (2010) · Blood · doi:10.1182/blood-2009-09-238832 · Cited by 116
Immune escape by Epstein Barr virus associated malignancies
Münz, C., & Moormann, A. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.10.002 · Cited by 110
Clinical and laboratory presentation of EBV positive infectious mononucleosis in young adults
Grotto, I., Mimouni, D., Huerta, M., Mimouni, M., Cohen, D., Robin, G., Pitlik, S. D., & Green, M. S. (2003) · Epidemiology and Infection · doi:10.1017/s0950268803008550 · Cited by 107
Sexual History and Epstein‐Barr Virus Infection
Crawford, D., Swerdlow, A. J., Higgins, C. D., McAulay, K. A., Harrison, N., Williams, H. J., Britton, K., & Macsween, K. F. (2002) · The Journal of Infectious Diseases · doi:10.1086/342596 · Cited by 107
Differential Kinetics and Specificity of EBV-Specific CD4+ and CD8+ T Cells During Primary Infection
Precopio, M., Sullivan, J. L., Willard, C., Somasundaran, M., & Luzuriaga, K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2590 · Cited by 106
Kanegane, H., Bhatia, K. G., Gutiérrez, M. I., Kaneda, H., Wada, T., Yachie, A., Seki, H., Arai, T., Kagimoto, S., Okazaki, M., et al. (1998) · Blood · doi:10.1182/blood.v91.6.2085 · Cited by 103
Seroepidemiologic Study of Epstein-Barr Virus Infections in a Rural Community
Cv, S., Henle, W., Henle, G., SMITH, M. H. D., & LeBlanc, D. (1975) · The Journal of Infectious Diseases · doi:10.1093/infdis/131.4.403 · Cited by 100
Patterns of cytokine gene expression in infectious mononucleosis
Foss, H., Herbst, H., Hummel, M., Araujo, I., Latza, U., Rancso, C., Dallenbach, F., & Stein, H. (1994) · Blood · doi:10.1182/blood.v83.3.707.707 · Cited by 91
A virologic pilot study of valacyclovir in infectious mononucleosis
Balfour, H. H., Hokanson, K. M., Schacherer, R. M., Fietzer, C. M., Schmeling, D. O., Holman, C., Vezina, H. E., & Brundage, R. C. (2007) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.02.002 · Cited by 90
Self-citationMononucleosis and Athletic Participation: An Evidence-Based Subject Review
Putukian, M., O’Connor, F. G., Stricker, P. R., McGrew, C. A., Hosey, R. G., Gordon, S. M., Kinderknecht, J. J., Kriss, V. M., & Landry, G. L. (2008) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0b013e31817e34f8 · Cited by 85
Hudnall, S. D., Chen, T., Allison, P. M., Tyring, S. K., & Heath, A. (2008) · Transfusion · doi:10.1111/j.1537-2995.2008.01685.x · Cited by 77
Ebrahimi, B., Dutia, B. M., Brownstein, D. G., & Nash, A. A. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64683-4 · Cited by 72
Gotoh, K., Ito, Y., Shibata‐Watanabe, Y., Kawada, J., Takahashi, Y., Yagasaki, H., Kojima, S., Nishiyama, Y., & Kimura, H. (2008) · Clinical Infectious Diseases · doi:10.1086/587671 · Cited by 70
Regulatory T cell activity in primary and persistent Epstein–Barr virus infection
Wingate, P. J., McAulay, K. A., Anthony, I., & Crawford, D. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21445 · Cited by 69
Optimal treatment for chronic active Epstein–Barr virus disease
Cohen, J. I. (2008) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2008.01095.x · Cited by 59
Antibodies to gp350/220 Enhance the Ability of Epstein-Barr Virus To Infect Epithelial Cells
Turk, S. M., Jiang, R., Chesnokova, L. S., & Hutt‐Fletcher, L. M. (2006) · Journal of Virology · doi:10.1128/jvi.00622-06 · Cited by 59
Kellerman, S., McCombs, K., Ray, M., Baughman, W., Reeves, M. W., Popović, T., Rosenstein, N. E., Farley, M. M., Blake, P. A., Stephens, D. S., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/341067 · Cited by 54
EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells
Xiao, J., Palefsky, J. M., Herrera, R., Berline, J. W., & Tugizov, S. M. (2009) · Virology · doi:10.1016/j.virol.2009.03.030 · Cited by 51
Characterization of the Epstein–Barr virus glycoprotein BMRF-2
Xiao, J., Palefsky, J. M., Herrera, R., & Tugizov, S. M. (2006) · Virology · doi:10.1016/j.virol.2006.09.047 · Cited by 49
Infectious mononucleosis: return to play
Auwaerter, P. G. (2004) · Clinics in Sports Medicine · doi:10.1016/j.csm.2004.02.005 · Cited by 45
Lee, K. S., Groshong, S. D., Cool, C. D., Kleinschmidt-DeMasters, B. K., & van Dyk, L. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0291 · Cited by 42
A virtual look at Epstein–Barr virus infection: Simulation mechanism
Shapiro, M., Duca, K., Lee, K., Delgado‐Eckert, E., Hawkins, J. B., Jarrah, A. S., Laubenbacher, R., Polys, N. F., Hadinoto, V., & Thorley‐Lawson, D. A. (2008) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2008.01.032 · Cited by 40
Figueira-Silva, C. M., & Pereira, F. E. L. (2004) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822004000500008 · Cited by 40
Blake, J. M., Edwards, J. M., Fletcher, W., McSwiggan, D. A., & Pereira, M. S. (1976) · Journal of Clinical Pathology · doi:10.1136/jcp.29.9.841 · Cited by 24
Cellular therapy of Epstein–Barr-virus-associated post-transplant lymphoproliferative disease
Heslop, H. E., Savoldo, B., & Rooney, C. M. (2004) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.05.007 · Cited by 24
Andrews, D. M., Andoniou, C. E., Fleming, P., Smyth, M. J., & Degli‐Esposti, M. A. (2008) · Journal of Virology · doi:10.1128/jvi.02127-07 · Cited by 23
Schuster, V. H., Herold, M., WACHTER, H., & Reibnegger, G. J. (1993) · Infection · doi:10.1007/bf01728890 · Cited by 20
Epstein‐Barr Virus Vaccine for the Prevention of Infectious Mononucleosis—and What Else?
Balfour, H. H. (2007) · The Journal of Infectious Diseases · doi:10.1086/523815 · Cited by 19
Self-citation
Cited by
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Herpesviruses: latency and reactivation – viral strategies and host response
Grinde, B. (2013) · Journal of Oral Microbiology · doi:10.3402/jom.v5i0.22766 · Cited by 489
Epstein-Barr Virus and Systemic Autoimmune Diseases
Houen, G., & Trier, N. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.587380 · Cited by 379
Allen, U. D., Preiksaitis, J. K., & Practice, T. A. I. D. C. O. (2019) · Clinical Transplantation · doi:10.1111/ctr.13652 · Cited by 375
Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation
Gold, J. E., Okyay, R. A., Licht, W. E., & Hurley, D. J. (2021) · Pathogens · doi:10.3390/pathogens10060763 · Cited by 371
Metadata
- Authors
- Odumade, O. A., Hogquist, K. A., & Balfour, H. H.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2011-01
- Volume
- 24
- Issue
- 1
- Pages
- 193-209
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2158114211
- Cited by
- 458
- References
- 116
- FWCI
- 10.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.